0001209191-23-038804.txt : 20230621 0001209191-23-038804.hdr.sgml : 20230621 20230621164033 ACCESSION NUMBER: 0001209191-23-038804 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230616 FILED AS OF DATE: 20230621 DATE AS OF CHANGE: 20230621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dubovsky Filip CENTRAL INDEX KEY: 0001977361 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 231030433 MAIL ADDRESS: STREET 1: C/O NOVAVAX INC. STREET 2: 21 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 21 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-16 0 0001000694 NOVAVAX INC NVAX 0001977361 Dubovsky Filip C/O NOVAVAX, INC. 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 0 1 0 0 President, R&D 0 Common Stock 2023-06-16 4 M 0 4155 8.04 A 47065 D Common Stock 2023-06-16 4 F 0 2007 8.04 D 45058 D Restricted Stock Units 2023-06-16 4 M 0 4155 0.00 D Common Stock 4155 0 D The shares were received by the reporting person in connection with vesting of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the June 16, 2020 grant date, in each case subject to continued employment with the Company through such vesting date. /s/ John A. Herrmann III, Attorney-in-Fact 2023-06-21